Table 1.
Relationship of circFBXO11 level with HCC patients’ clinicopathological
| Parameters | circFBXO11 | P‐value | ||
|---|---|---|---|---|
| Low (20) | High (20) | |||
| Gender | ||||
| Male | 24 | 11 | 13 | .613 |
| Female | 16 | 9 | 7 | |
| Age | ||||
| <50 y | 22 | 11 | 11 | .879 |
| ≥50 y | 18 | 9 | 9 | |
| Histological grade | ||||
| Well | 13 | 6 | 7 | .754 |
| Moderately | 17 | 9 | 8 | |
| Poorly | 10 | 5 | 5 | |
| Tumour size | ||||
| <5 cm | 13 | 5 | 8 | .026* |
| ≥5 cm | 27 | 15 | 12 | |
| Lymphatic metastasis | ||||
| Yes | 24 | 11 | 13 | .137 |
| No | 16 | 9 | 7 | |
| TNM stage | ||||
| I‐II | 15 | 6 | 9 | .115 |
| III‐IV | 25 | 14 | 11 | |
| AFP (ng/mL) | ||||
| <400 | 12 | 4 | 8 | .032* |
| ≥400 | 28 | 16 | 12 | |
AFP, alpha‐fetoprotein; TNM, tumour‐node‐metastasis.
*
P < .05.